Illustrative image.
Auvelity
Dextromethorphan Hydrobromide And Bupropion Hydrochloride
$7740.00
45/105mg · 6 × 30 tablets · 3 months supply
BrandBranded medicine· By Axsome Therapeutics
$2580.00 per month
How long a supply?
Test mode: no payment is taken. View cart
Annual cost
$30960a year at this pack size
Prescription required
Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.
FDA boxed warningSuicidal thoughts and behaviors
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and emergence of suicidal thoughts and behaviors. AUVELITY is not approved for use in pediatric patients.
Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. AUVELITY is not approved for use in pediatric patients.
About Auvelity
Overview
Auvelity is a prescription tablet containing dextromethorphan hydrobromide and bupropion hydrochloride. It is used to treat major depressive disorder in adults and agitation associated with dementia due to Alzheimer’s disease. It is not intended for as-needed treatment of this agitation. Dextromethorphan acts on certain brain receptors, while bupropion slows its breakdown to increase its level in the body; exactly how these actions help treat these conditions is unclear.
What it treats
- Major depressive disorder (MDD) in adults. - Agitation associated with dementia due to Alzheimer’s disease. Auvelity is not indicated for as-needed treatment of this agitation.
Safety information
Side effects
Common side effects reported in major depressive disorder studies include dizziness, headache, diarrhea, sleepiness, dry mouth, sexual problems and excessive sweating. In studies of agitation associated with dementia due to Alzheimer’s disease, the most common side effects were dizziness and indigestion. Serious side effects warranting medical attention include suicidal thoughts or behaviors, particularly in adolescents and young adults; seizures; increased blood pressure; mania or hypomania; psychosis or other changes in mental state or behavior; angle-closure glaucoma; serotonin syndrome; and low blood sodium. Seek urgent medical help for suicidal thoughts or behaviors or a seizure. Contact a doctor promptly if changes in mental state or behavior occur. Treatment must be stopped if a seizure or serotonin syndrome occurs. The risk of serotonin syndrome is increased when Auvelity is taken with SSRI or tricyclic antidepressants. Blood pressure should be checked before treatment and monitored during treatment. Dizziness may increase the risk of falls; take precautions and use caution when operating machinery. Auvelity may harm an unborn baby. Contact your prescriber if you are pregnant or planning pregnancy; the label advises stopping treatment during pregnancy and using an alternative treatment when planning pregnancy.
FDA boxed warning
Suicidal thoughts and behaviors
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and emergence of suicidal thoughts and behaviors. AUVELITY is not approved for use in pediatric patients.
Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. AUVELITY is not approved for use in pediatric patients.
A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.
When to call your doctor
If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.
Before taking this medicine
Do not take Auvelity if you: • Have a seizure disorder. • Have or have previously had bulimia or anorexia nervosa. • Are abruptly stopping alcohol, benzodiazepines, barbiturates or antiepileptic medicines. • Take a monoamine oxidase inhibitor (MAOI), including linezolid or intravenous methylene blue, or have stopped an MAOI within the past 14 days. Do not start an MAOI within 14 days of stopping Auvelity. These combinations can cause serious, potentially fatal reactions. • Are allergic to dextromethorphan, bupropion or any other ingredient in Auvelity. Auvelity should be avoided in people with severe liver impairment. It may harm an unborn baby; the label advises stopping treatment during pregnancy and using an alternative treatment when planning pregnancy. Contact your prescriber if you are pregnant or planning pregnancy. Breastfeeding is not recommended during treatment. Auvelity can cause seizures, raise blood pressure and trigger mania or hypomania. Blood pressure should be checked before treatment and periodically during treatment, and patients should be screened for bipolar disorder. Untreated narrow drainage angles in the eyes increase the risk of angle-closure glaucoma. Low blood sodium can also occur. Taking Auvelity with an SSRI or tricyclic antidepressant increases the risk of serotonin syndrome. Treatment must be stopped if serotonin syndrome or a seizure occurs. Contact a healthcare professional if psychosis or other unusual mental or behavioural changes occur. Auvelity may cause dizziness; take precautions to prevent falls and use caution when operating machinery.
Interactions
Do not take Auvelity with a monoamine oxidase inhibitor (MAOI), including linezolid or intravenous methylene blue. Combining them increases the risk of a dangerous rise in blood pressure and serotonin syndrome. At least 14 days must pass between stopping an MAOI and starting Auvelity, or stopping Auvelity and starting an MAOI. Other interactions to discuss with your doctor include: • Medicines that affect serotonin: these increase the risk of serotonin syndrome and require monitoring. • Medicines that increase seizure risk: combining these with Auvelity may further increase that risk. If a seizure occurs, Auvelity must be stopped and not restarted. • Strong CYP2D6 inhibitors: these increase dextromethorphan levels and may cause sleepiness or dizziness. Your prescriber will need to adjust treatment. • Strong CYP2B6 inducers: these can lower dextromethorphan and bupropion levels, making Auvelity less effective. This combination should be avoided. • Medicines processed by CYP2D6: Auvelity can increase levels of some of these medicines. It can also reduce the effectiveness of medicines that need CYP2D6 to become active. Your prescriber may need to adjust treatment. • Digoxin: Auvelity may lower digoxin levels, so blood-level monitoring is needed. • Dopaminergic medicines, including levodopa and amantadine: use with bupropion has been associated with nervous system toxicity, including restlessness, agitation, shaking, coordination or walking difficulties, vertigo and dizziness. Minimize or avoid alcohol during treatment. Bupropion can reduce alcohol tolerance or increase adverse effects on mood, thinking or behaviour. Auvelity can cause a false-positive urine screening result for amphetamines, even after treatment has stopped. Let the clinician arranging the test know you take Auvelity; a confirmatory test can distinguish bupropion from amphetamines.
Using Auvelity
Dosing
Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.
Storage
Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.
Clinical information on this page is summarised from the US FDA label AUVELITY (DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE) TABLET, MULTILAYER, EXTENDED RELEASE AUVELITY (DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE) KIT [AXSOME THERAPEUTICS, INC.] (DailyMed, retrieved 19 September 2026).
Reviews
No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.
- Every prescription order is checked by a licensed pharmacist before dispensing.
- Payment pages are encrypted and card details never reach our servers.
- We ship internationally, with cold-chain packing where a medicine needs it.
Related medicines
Ludiomil
Maprotiline
By UniPharm
Tablets · from 30 per pack
Also for depression
Generic $21.00
Manerix
Moclobemide
Tablets · from 30 per pack
Also for depression
Brand from $39.00
Edronax
Reboxetine
By Pfizer
Tablets · from 60 per pack
Also for depression
Brand $50.00
Prizma
Prizma
Also for depression
Pack sizes and pricing not listed yet